Essential Head and Neck Oncology and Surgery These include solid-tumor cancers such as melanoma, colorectal, breast and prostate cancer, as well asmalignancies of the blood, such as leukemia and lymphoma. 2023 The Regents of the University of California. Dr. Stefan O. Ciurea is a UCI Health hematologist and director of the Hematopoietic Stem Cell Transplantation and Cellular Therapy Program at the Chao Family Comprehensive Cancer Center. Our researchers are at the forefront not only in treating cancer, but also in preventing it. Michelle Clark-Salib fought cancer and delivered a healthy son, COVID-19 vaccine and protecting your health , National Cancer Institute-designated comprehensive cancer center in Orange County, only adult hematopoietic stem-cell transplant services, Our cancer experts also are available to provide second opinions , Hematology-Oncology Services (Leukemia, Lymphoma and Myeloma), Quality OncologyPractice Initiative (QOPI) CertificationProgram, Blue Distinction Center for Complex and Rare Cancers, Learn more about our Blue Distinction Center designation , 53 National Cancer Institute (NCI)-designated comprehensive cancer centers, HIPEC, or hyperthermic intraoperative peritoneal chemotherapy, Stem cell transplant wards off aggressive lymphoma, Dedicated to cancer research & treatment (video), OCMA honors UCI Health 'Physicians of Excellence', 2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research, UCI Health honored for surgical safety and excellence, UCI opens first natural killer cell clinical trial for recurrent glioblastoma, $8 million grant expands access to UCI stem cell clinical trials, Gastric cancer patient gets new lease on life, Riding tall a decade after prostate surgery, A novel approach to advanced stomach cancer, Take a virtual tour of the infusion center at UCI Health Cancer Center Newport , Integrate innovative research with the most advanced diagnostics, treatments, rehabilitation and, Offer one of the largest early-phase clinical trials programs in Southern California, giving our patients access to promising therapies before they are available elsewhere. Methods: This was a retrospective study of patients in the California Cancer Registry aged 18 to 79 years with recent diagnoses of anal squamous cell carcinoma. These include state-of-the-art drugs and new biological and immunological modifiers being investigated in clinical trials. IJMS | Free Full-Text | Targeting Cellular Retinoic Acid Binding UCI is seeking a dynamic leader with strong credentials in clinical medicine and basic, translational, or clinical research. He then completed a fellowship in hematology-oncology at University of Illinois at Chicago College of Medicine, followed by a fellowship in stem cell transplantation and cellular therapy at the University of Texas MD Anderson Cancer Center in Houston. This, we believe, is vital to our ability to continue to achieve excellence in serving our richly diverse community through our discover, teach, and heal mission. If you are not already licensed in the state, contact the Medical Board of California online or at 1426 Howe Ave., Suite 54, Sacramento, CA 95825-3236. For more information, please contact us at ucstudy@hs.uci.edu or 877-827-8839. Here at UCI Department of Medicine, we highly value diversity. Read More . We are also a Blue Distinction Center for Complex and Rare Cancers. The division's faculty members serve patients with hematologic and oncologic disorders at the medicalcenter, which is consistently listedamong the top 50 U.S. hospitals by U.S. News & World Report, as well as at the VA Long Beach Healthcare System. Phone: (714) 456-5153 Fax: (714) 456-2242 Email: moyersj@uci.edu University of California, Irvine 200 S. Manchester Ave. Suite 400, Room 411 Mail Code: 4061 Orange, CA 92868 Research Interests Melanoma, skin cancers, merkel cell carcinoma, cutaneous squamous cell carcinoma, sarcoma, phase 1, clinical/translational research in melanoma and sarcoma UC Irvine - Faculty Profile System - Nataliya Mar MD Candidates must be a U.S. citizen, permanent resident orhold a J-1 visa with ECFMG sponsorshipat the time of application submission. This button displays the currently selected search type. Our oncologists are highly skilled in the leading-edge treatments and many also participate in clinical trials. Faculty | UCI Chao Family Comprehensive Cancer Center Fellows participate in weekly didactic lectures as well as academic activities including journal club, M&M, quality improvement, hematology conference, and disease specific lectures. It also underscores our commitment to cancer prevention research as well as our extensive community outreach and education programs. Cancer Support and Survivorship Services focuses on treating the whole patient, providing assistance with symptom management, supportive care and survivorship planning. We are recognized for delivering the highest quality care by the Quality OncologyPractice Initiative (QOPI) CertificationProgram, which is an affiliate of the American Society of Clinical Oncology. A method of treatment in our research was used to make an oral vaccine that packaged the inactive PEDV . May 18-22, 2012 15. This designation is given by the Blue Cross Blue Shield Association to centers offering the full range of patient assessment, treatment planning, complex inpatient care and major surgical treatments for adults all delivered by teams with distinguished expertise and subspecialty training for complex and rare cancers. For more information, call us at 714-456-8000 or fill out an appointment request form Individual Treatment Plans Medical Education. UC Irvine hiring Director, Early Phase Clinical Trials and Precision After more than a decade of work helping patients like Allen Fremont, Dr. Sai-hong Ignatius Ou has gained FDA approval for a drug treatment that targets mutations of non-small cell lung cancers. A disability plan is available through the Irvine House Staff Association. Cancers | Free Full-Text | Population-Based Analysis of National He sees patients at the UCI Health Chao Family Comprehensive Cancer Center in Orange. UC Irvine Medical Center/Chao Family Comprehensive Cancer Center ( Site 0092) Orange: California: 92868: United States: . No cancer is rare to us. MD , Full Professor of Medical Oncology. To solve this problem, a privacy-preserving . During the first year fellows acquire a panel of outpatients that are followed longitudinally throughout fellowship training in their continuity clinics. State-of-the-art care is provided including bone marrow transplantation for qualified individuals. This recognition reflects our expertise in translating leading-edge scientific findings into clinical cancer treatment on all levels. We provide undergraduate, postgraduate and continuing medical education programs to educate the next generation of physicians and scientists for careers in clinical and academic medicine as well as for laboratory research. UCI Health - Chao Family Comprehensive Cancer Center - Yelp These may include magnetic resonance imaging (MRI), computed tomography (CT) scans, positron emission tomography (PET) scans, endoscopy, X-rays and biopsies. Fellows receive three weeks vacation per year. 15th Annual Hematologic Malignancies Demystified Unraveling the Challenges of Diagnosis and Treatment in Malignant Hematology. Appointment as Clinical Staff Investigator within the Chao Family Comprehensive Cancer Center [P30 Cancer Center Support Grant] April 2019- present (one of only two positions at UCI) 16. Chapter 21. Our modern infusion center allows our patients to undergo chemotherapy in privacy and comfort, attended by our team of experienced and compassionate nurses. Residents | Kaiser Permanente Undergraduate & Graduate Medical Our UCI Health hematologists and hematological oncologists include: Sign up for our monthly e-newsletter and get the latest health tips and stories from our Live Well blog . Cancer Center | UCI Health | Orange County, CA In addition to conventional treatments, our medical oncologists are also active in clinical testing of novel therapies. Our physicians are at the forefront of the latest research and clinical trials and are experts in leading-edge therapies for diseases of the bone marrow offering you only the best care. Experience being involved in non-cancer therapeutics development in addition to the cancer experience is a plus Treatments and therapies may include surgery, radiation and chemotherapy, individually or in combination, depending on your personal health and the type and stage of your cancer. Under the direct supervision of faculty members fellows receive a thorough grounding in solid tumor oncology, general hematology, and hematologic malignancies. Who We Are - UCLA Hematology/Oncology Fellowship Program Hematology-Oncology Clinical Interests bone marrow transplantation, chimeric antigen receptor (CAR) T-cell therapy, natural killer cell therapy MyChart patient portal offers a convenient and secure way to manage your healthcare online. We also offer additional services, such as dietary guidance, pain management, counseling and support groups. Malignant blood diseases such as acute and chronic leukemia, lymphoma, myeloma and other bone marrow disorders often involve a complex treatment plan. Telephone consultation is available 24 hours a day. Fellowship candidates must have completed an ACGME-accredited Internal Medicine residency program. As a university medical center, we typically have dozens of clinical trials in progress addressing different conditions, including "refractory" cancers that do not respond to standard treatments. We emphasize a coordinated, patient-centered approach to care, with our multidisciplinary team of cancer specialists working together to ensure you and your loved ones have the best possible experience. Incumbent will be responsible for the development and growth of UCI's early phase clinical trials portfolio for both oncology and non-oncology indications, across the UCI Chao Family Comprehensive Cancer Center's (CFCCC) Stern Center for Cancer Clinical Trials & Research (Stern Center), the UCI Center for Clinical Research (CCR), and the UCI Alpha Stem Cell Clinic (ASCC).